Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
SO4 Sulfate ion
JGQ 4-[(2~{S},4~{S})-4-ethoxy-1-[(5-methoxy-7-methyl-1~{H}-indol-4-yl)methyl]piperidin-2-yl]benzoic acid
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 6RAV   PDBj   RCSB PDB   PDBe
Header : HYDROLASE
Title : Complement factor B protease domain in complex with the reversible inhibitor 4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid
Release Data : 2019-04-17
Compound :
mol_id molecule chains synonym
1 Complement factor B AAA,BBB C3/C5 convertase,Glycine-rich beta glycoprotein,GBG,PBF2,Properdin factor B
ec: 3.4.21.47
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Drosophila melanogaster  (taxid:7227)
gene: CFB, BF, BFD
Authors : Adams, C.M., Sellner, H., Ehara, T., Mac Sweeney, A., Crowley, M., Anderson, K., Karki, R., Mainolfi, N., Valeur, E., Sirockin, F., Gerhartz, B., Erbel, P., Hughes, N., Smith, T.M., Cumin, F., Argikar, U., Mogi, M., Sedrani, R., Wiesmann, C., Jaffee, B., Maibaum, J., Flohr, S., Harrison, R., Eder, J.
Keywords : Complement, immune, inhibitor, c3 convertase, HYDROLASE
Exp. method : X-RAY DIFFRACTION ( 1.700 Å )
Citation :

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.

Schubart, A.,Anderson, K.,Mainolfi, N.  et al.
(2019)  Proc.Natl.Acad.Sci.USA  116 : 7926 - 7931

PubMed: 30926668
DOI: 10.1073/pnas.1820892116

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.

Schubart, A.,Anderson, K.,Mainolfi, N.  et al.
(2019)  Proc.Natl.Acad.Sci.USA  116 : 7926 - 7931

PubMed: 30926668
DOI: 10.1073/pnas.1820892116

Chain : AAA, BBB
UniProt : P00751 (CFAB_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
Cleavage of Arg-|-Ser bond in complement component C3 alpha- chain to yield C3a and C3b, and Arg-|-Xaa bond in complement component C5 alpha-chain to yield C5a and C5b. 3.4.21.47 -
-